BioWorld

April 22, 2005

View Archived Issues

TKT Absorbed For $1.6B As Shire Fattens Pipeline

In what could be the largest acquisition of 2005 - and certainly the largest so far - Shire Pharmaceuticals Group plc has nabbed Transkaryotic Therapies Inc. in a deal worth $1.6 billion. (BioWorld Today) Read More

Pozen's Stock Gains Ground On Trexima's Positive Migraine Data

Read More

Autophagy Goes From Good To Bad In Neurodegeneration

Read More

Genzyme Beats Consensus, Increases Full-Year Guidance

Read More

Other News To Note

Read More

Appointments And Advancements

Read More